Since highly versatile human stem cells were discovered at the University of Wisconsin–Madison nearly 20 years ago, their path to the market and clinic has been slowed by a range of complications.
Both embryonic stem cells and induced pluripotent stem cells are valued for their ability to form any cell in the body.